- Home
- LGL vs TENX Comparison
LGL vs TENX Comparison
Compare LGL & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGL
- TENX
- Stock Information
- Founded
- LGL 1917
- TENX 1967
- Country
- LGL United States
- TENX United States
- Employees
- LGL N/A
- TENX N/A
- Industry
- LGL Industrial Machinery/Components
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- LGL Technology
- TENX Health Care
- Exchange
- LGL Nasdaq
- TENX Nasdaq
- Market Cap
- LGL 34.1M
- TENX 27.3M
- IPO Year
- LGL N/A
- TENX N/A
- Fundamental
- Price
- LGL N/A
- TENX $7.43
- Analyst Decision
- LGL
- TENX Strong Buy
- Analyst Count
- LGL 0
- TENX 3
- Target Price
- LGL N/A
- TENX $16.67
- AVG Volume (30 Days)
- LGL 10.0K
- TENX 141.4K
- Earning Date
- LGL 11-12-2025
- TENX 11-12-2025
- Dividend Yield
- LGL N/A
- TENX N/A
- EPS Growth
- LGL N/A
- TENX N/A
- EPS
- LGL 0.04
- TENX N/A
- Revenue
- LGL $4,178,000.00
- TENX N/A
- Revenue This Year
- LGL N/A
- TENX N/A
- Revenue Next Year
- LGL N/A
- TENX N/A
- P/E Ratio
- LGL $155.66
- TENX N/A
- Revenue Growth
- LGL 6.34
- TENX N/A
- 52 Week Low
- LGL $5.60
- TENX $3.56
- 52 Week High
- LGL $9.74
- TENX $8.24
- Technical
- Relative Strength Index (RSI)
- LGL 45.12
- TENX 62.96
- Support Level
- LGL $6.29
- TENX $7.49
- Resistance Level
- LGL $6.52
- TENX $8.24
- Average True Range (ATR)
- LGL 0.22
- TENX 0.42
- MACD
- LGL -0.02
- TENX -0.02
- Stochastic Oscillator
- LGL 30.00
- TENX 57.45
About LGL LGL Group Inc. (The)
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.